Earnings Results: Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth
Drugmaker raises full-year sales outlook but cuts earnings guidance as it digests recent deals
Drugmaker raises full-year sales outlook but cuts earnings guidance as it digests recent deals